Report cover image

Cell and Gene Therapy Orchestration Solutions

Publisher IDC
Published Mar 25, 2026
Length 8 Pages
SKU # IDC21046754

Description

This IDC Perspective frames CGT’s “batch size of one” reality and positions orchestration as the workflow integration/control layer needed to scale autologous patient-product-patient operations. It spotlights the critical challenges, ensuring a secure COI/COC across a multi-enterprise network, constraint-heavy scheduling, interoperability across MES/LIMS/QMS/ERP and partner systems, and GxP-ready governance/auditability. It identifies specific use cases where AI can add value, along with the challenges. It provides practical buyer guidance and KPIs for CGT orchestration solutions.“The future of precision medicine runs on CGT orchestration solutions: smart execution layers that connect manufacturing, QC, and cryologistics. They digitize COI/COC across the patient-product life cycle, compress vein-to-vein timelines, and optimize clinical outcomes,” said Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology, IDC.

Table of Contents

8 Pages

Executive snapshot

Key takeaways

Recommended actions

Situation overview

CGT orchestration solutions — key drivers

Orchestrating the future of CGT manufacturing and supply chain

Key challenges that orchestration must solve

Embedding the AI narrative in CGT orchestration solutions

The challenges in leveraging AI in CGT orchestration solutions

Conclusion

Advice for the technology buyer

Learn more

Related research

Synopsis

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.